// App-Quantinova.ai

TCT-608 : Implementation of Bayesian Study Design in the SPYRAL HTN-OFF MED Pivotal Trial

Researchers

Presenter

  • Michael Bohm

Principal Investigators

  • Raymond Townsend

  • Michael Weber

  • David Kandzari

  • Felix Mahfoud

  • Kazuomi Kario

  • Roland Schmieder

  • Konstantinos Tsioufis

  • Vanessa DeBruin

  • Graeme Hickey

  • Martin Fahy

  • Stuart Pocock

Medical Centers

  • University Hospital of Saarland, Homburg/Saar, Germany

  • Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania

  • Jichi Medical University of Medicine, Tochigi, Japan

  • First Cardiology Clinic, Medical School, National and Kapodistrian University of Athens, Hippokration, Athens, Greece

  • Medtronic, Santa Rosa, California

  • University Hospital Erlangen, Erlangen, GERMANY

  • Medtronic, Liverpool, United Kingdom

  • London School of Hygiene and Tropical Medicine, London, United Kingdom

  • Piedmont Heart Institute, Atlanta, Georgia

  • Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Homburg/Saar, Germany

  • SUNY Downstate Medical Center, Brooklyn, New York

Locations

  • Germany

  • United Kingdom

  • Greece

  • United States

  • Japan

  • Georgia

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Cartilage oligomeric matrix protein

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • Randomized

  • Adaptive

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved